Dr. Wenqing Xu received a new NIH grant entitled: "Structural Analysis of Cancerous Inhibitor of PP2A (CIP2A)". The project aims to determine the three-dimensional structure of CIP2A, which is essential for understanding CIP2A function and how to develop CIP2A inhibitors for cancer treatment.CIP2A inhibits tumor suppressor activity of PP2A in human malignancies and is one of the most frequently overexpressed oncoproteins.
CONGRATULATIONS TO DR. RACHEL WONG!
Dr. Wong was awarded the Brian Boycott Prize at the FASEB Conference on Retinal Neurobiology and Visual processing. This award honors her lifetime achievements in retinal neuroscience.